Many of these genes, including ABCB4 (MDR3), ADAM22, and DBF4, have been implicated in cancer development and MDR, and are considered possible therapeutic targets [132,133,134,135,136,137,138,139,140,141,142,143,144,145,146]. Here, ABCB4 is linked to cancer.